Treatment for prevention of HIV transmission in a localised epidemic: The case for South Australia

Sexual Health

Volumn 8, Issue 3, 2011, Pages 280-294

  Heymer, Kelly Jean ^a   Wilson, David P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

HIV; mathematical model; men who have sex with men; South Australia; test and treat

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; AUSTRALIA; CD4 LYMPHOCYTE COUNT; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MALE HOMOSEXUAL; MATHEMATICAL MODEL; VIRUS TRANSMISSION;

AIDS SERODIAGNOSIS; ANTI-HIV AGENTS; EARLY DIAGNOSIS; EPIDEMICS; FORECASTING; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MODELS, THEORETICAL; SOUTH AUSTRALIA; TREATMENT OUTCOME; UNSAFE SEX;

EID: 84860389836     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH10084     Document Type: Article

References (59)

1. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009; 373: 48-57. doi:10.1016/S0140-6736(08)61697-9
2. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire- Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342: 921-9. doi:10.1056/NEJM200003303421303
3. Vernazza PL, Gilliam BL, Dyer J, Fiscus SA, Eron JJ, Frank AC, et al. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS 1997; 11: 987-93. doi:10.1097/00002030-199708000-00006
4. Vernazza PL, Troiani L, Flepp MJ, Cone RW, Schock J, Roth F, et al. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS 2000; 14: 117-21. doi:10.1097/00002030-200001280-00006
5. Zhang H, Dornadula G, Beumont M, Livornese L Jr, Van Uitert B, Henning K, et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998; 339: 1803-9. doi:10.1056/NEJM19981217339 2502
6. Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, et al. Decline in HIV infectivity following the introductionof highly active antiretroviral therapy. AIDS 2004; 18: 81-8. doi:10.1097/00002030-200401020- 00010
7. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010; 375: 2092-8. doi:10.1016/S0140- 6736(10)60705-2
8. Attia S, Egger M, Müller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23: 1397-404. doi:10.1097/QAD.0b013e32832b7dca
9. Wilson DP. Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet 2009; 373: 1077-8, author reply 1080-1. doi:10.1016/S0140- 6736(09)60641-3
10. Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA 2009; 301: 2380-2. doi:10.1001/jama.2009. 828
11. Wagner BG, Kahn JS, Blower S. Should we try to eliminate HIV epidemics by using a 'test and treat' strategy? AIDS 2010; 24: 775-6. doi:10.1097/QAD. 0b013e3283366782
12. Wilson DP. Evidence is still required for treatment as prevention for riskier routes of HIV transmission. AIDS 2010; 24: 2891-2. doi:10.1097/QAD. 0b013e328340871d
13. Das M, Lee Chu P, Santos G-M, Scheer S, Vittinghoff E, McFarland W, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010; 5: e11068. doi:10.1371/journal.pone. 0011068
14. van Griensven F, de Lind van Wijngaarden JW, Baral S, Grulich A. The global epidemic of HIV infection among men who have sex with men. Curr Opin HIV AIDS 2009; 4: 300-7. doi:10.1097/COH.0b013e32832c3bb3
15. Grulich AE, Kaldor JM. Trends in HIV incidence in homosexual men in developed countries. Sex Health 2008; 5: 113-8. doi:10.1071/ SH07075
16. Sullivan PS, Hamouda O, Delpech V, Geduld JE, Prejean J, Semaille C, et al. Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996-2005. Ann Epidemiol 2009; 19: 423-31. doi:10.1016/j.annepidem.2009.03.004
17. Jin F, Jansson J, Law M, Prestage GP, Zablotska I, Imrie JCG, et al. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 2010; 24: 907-13. doi:10.1097/QAD.0b013e3283372d90
18. Lima VD, Hogg RS, Montaner JS. Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada. PLoS One 2010; 5: e10991. doi:10.1371/journal.pone.0010991
19. National Centre in HIV Epidemiology and Clinical Research. In:McDonald A, editor. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia. Annual surveillance report. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales; 2009.
20. Wilson DP, Hoare A, Regan D, Wand H, Law M. Mathematical models to investigate recent trends in HIV notifications among men who have sex with men in Australia. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales; 2008.
21. Prestage G, Ferris J, Grierson J, Thorpe R, Zablotska I, Imrie J, et al. Homosexual men in Australia: population, distribution and HIV prevalence. Sex Health 2008; 5: 97-102. doi:10.1071/SH07080.
22. Rawstorne P, Holt M, Kippax S, Worth H, Wilkinson J, Bittman M.E-Male survey 2008: key findings from a national online survey of men who have sex with men. Sydney: National Centre in HIV Social Research; 2009.
23. Frankland A, Zablotska I, Prestage G, O'Connor S, Martin P, Imrie J. Adelaide gay community periodic survey. Sydney: National Centre in HIV Social Research, University of New South Wales; 2007.
24. Kippax S, Connell R, Dowsett GW, Crawford J. Sustaining safe sex: gay communities respond to AIDS. London: Routledge; 1993.
25. Wilson DP, Hoare A, Regan DG, Law MG. Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men. Sex Health 2009; 6: 19-33. doi:10.1071/SH08081
26. Prestage G, Hudson J, Bradley J, Down I, Sutherland R, Corrigan N, et al. TOMS: three or more study. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales; 2008.
27. Lima VD, Johnston K, Hogg RS, Levy AR, Harrigan PR, Anema A, et al. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis 2008; 198: 59-67. doi:10.1086/588673
28. Velasco-Hernandez JX, Gershengorn HB, Blower SM. Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis 2002; 2: 487-93. doi:10.1016/S1473-3099(02)00346-8
29. Baggaley RF, Garnett GP, Ferguson NM. Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med 2006; 3: e124. doi:10.1371/journal.pmed.0030124
30. Salomon JA, Hogan DR. Evaluating the impact of antiretroviral therapy on HIV transmission. AIDS 2008; 22(Suppl 1): S149-59.doi:10.1097/01.aids. 0000327636.82542.87
31. Johnston KM, Levy AR, Lima VD, Hogg RS, Tyndall MW, Gustafson P, et al. Expanding access to HAART: a cost-effective approach for treating and preventing HIV. AIDS 2010; 24: 1929-35. doi:10.1097/QAD.0b013e32833af85d
32. Jin F, Crawford J, Prestage GP, Zablotska I, Imrie J, Kippax SC, et al. Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS 2009; 23: 243-52. doi:10.1097/QAD.0b013e32831fb51a
33. Prestage G, McCann PD, Hurley M, Bradley J, Down I, Brown G. Pleasure and sexual health: The PASH Study, 2009. Sydney: National Centre in HIV Epidemiology and Clinical Research; 2010.
34. Kinloch-de Loës S, Hirschel BJ, Hoen B, Cooper DA, Tindall B, Carr A, et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995; 333: 408-13. doi:10.1056/NEJM199508173330702
35. Hammer SM, Saag MS, Schechter M, Montaner JSG, Schooley RT, Jacobsen DM, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society - USA panel. JAMA 2006; 296: 827-43. doi:10.1001/jama.296.7.827
36. Rawstorne P, Holt M, Kippax S, Worth H, Wilkinson J, Bittman M. Supplemental data analysis to the E-Male survey: data comparisons of the E-Male survey in South Australia and the Adelaide Gay Community Periodic Survey. Sydney: NCHSR, University of New South Wales; 2009.
37. Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect 1999; 31: 272-9. doi:10.2307/2991537
38. Weller SC, Davis KR. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002; (1): CD003255. doi:10.1002/14651858.CD003255
39. Pinkerton SD, Abtramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med 1997; 44: 1303-12. doi:10.1016/ S0277-9536(96)00258-4
40. Weller SC. A meta-analysis of condom effectiveness in reducing sexually transmitted HIV. Soc Sci Med 1993; 36: 1635-44. doi:10.1016/0277-9536(93)90352-5
41. Fitch TJ, Stine C, Hager WD, Mann J, Adam MB, McIlhaney J. Condom effectiveness: factors that influence risk reduction. Sex Transm Dis 2002; 29: 811-7. doi:10.1097/00007435-200212000-00013
42. Van de Ven P, Mao L, Fogarty A, Rawstorne P, Crawford J, Prestage G, et al. Undetectable viral load is associated with sexual risk taking in HIV serodiscordant gay couples in Sydney. AIDS 2005; 19: 179-84. doi:10.1097/00002030-200501280-00010
43. National Centre in HIV Social Research. National Centre in HIV Social Research annual report of trends in behaviour. Sydney: NCHSR, University of New South Wales; 2006.
44. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of highrisk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005; 39: 446-53. doi:10.1097/01.qai.0000151079.33935.79
45. Cleary PD, Van Devanter N, Rogers TF, Singer E, Shipton-Levy R, Steilen M, et al. Behavior changes after notification of HIV infection. Am J Public Health 1991; 81: 1586-90. doi:10.2105/AJPH.81.12.1586
46. Colfax GN, Buchbinder SP, Cornelisse PGA, Vittinghoff E, Mayer K, Celum C. Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS 2002; 16: 1529-35. doi:10.1097/00002030- 200207260-00010
47. McCusker J, Stoddard AM, Mayer KH, Zapka J, Morrison C, Saltzman SP. Effects of HIV antibody test knowledge on subsequent sexual behaviors in a cohort of homosexually active men. Am J Public Health 1988; 78: 462-7. doi:10.2105/AJPH.78. 4.462
48. Saah AJ, Hoover DR, Weng S, Carrington M, Mellors J, Rinaldo CR Jr, et al. Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV- 1 infection. Multicenter AIDS Cohort Study. AIDS 1998; 12: 2107-13. doi:10.1097/00002030-199816000-00005
49. Smith DK, Valleroy LA, Warren DL, Vlahov D, Schuman P, Stein MD, et al. Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER)study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol 1997; 146: 459-69.
50. Valleroy LA, MacKellar DA, Karon JM, Rosen DH, McFarland W, Shehan DA, et al. HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group. JAMA 2000; 284: 198-204. doi:10.1001/jama.284.2. 198
51. Law MG, Prestage G, Grulich A, Van de Ven P, Kippax S. Modelling the effect of combination antiretroviral treatments on HIV incidence. AIDS 2001; 15: 1287-94. doi:10.1097/00002030-200107060-00011
52. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126: 946-54.
53. Worm SW, Friis-Møller N, Sabin CA, Sjøl A, Lundgren JD, Salbøl- Brandt R, et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS 2010; 24: 1537-48.
54. Ledergerber B. and The PLATO Collaboration. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. Lancet 2004; 364: 51-62. doi:10.1016/S0140-6736(04)16589-6
55. Jin F, Jansson J, Law M, Prestage GP, Zablotska I, Imrie JCG, et al. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 2010; 24: 907-13. doi:10.1097/ QAD.0b013e3283372d90
56. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM. Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 2008; 372: 314-20. doi:10.1016/S0140-6736(08)61115-0
57. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire- Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342: 921-9. doi:10.1056/NEJM200003303421303
58. Australian HIV Observational Database Annual Report. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales; 2009.
59. Lodwick RK, Smith CJ, Youle M, Lampe FC, Tyrer M, Bhagani S, et al. Stability of antiretroviral regimens in patients with viral suppression. AIDS 2008; 22: 1039-46. doi:10.1097/QAD.0b013e3282fec415